Patel Chem Specialities IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Jul 25 to Jul 29 2025
Price Band
₹84
Current GMP
₹110(30.95%)
Subscription
167.32 times
IPO Details
| IPO Date | July 25, 2025 to July 29, 2025 |
| Listing Date | August 1, 2025 |
| Face Value | ₹10 per share |
| Issue Price | ₹84 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 70,00,000 shares (aggregating up to ₹58.80 Cr) |
| Reserved for Market Maker | 3,53,600 shares (aggregating up to ₹2.97 Cr)Globalworth Securities Ltd. |
| Net Offered to Public | 66,46,400 shares (aggregating up to ₹55.83 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 1,78,70,000 shares |
| Share Holding Post Issue | 2,48,70,000 shares |
IPO Date
July 25, 2025 to July 29, 2025
Listing Date
August 1, 2025
Face Value
₹10 per share
Issue Price
₹84 per share
Lot Size
1,600 Shares
Sale Type
Fresh Capital
Total Issue Size
70,00,000 shares (aggregating up to ₹58.80 Cr)
Reserved for Market Maker
3,53,600 shares (aggregating up to ₹2.97 Cr)Globalworth Securities Ltd.
Net Offered to Public
66,46,400 shares (aggregating up to ₹55.83 Cr)
Issue Type
Bookbuilding IPO
Listing At
BSE SME
Share Holding Pre Issue
1,78,70,000 shares
Share Holding Post Issue
2,48,70,000 shares
IPO Subscription Details
| Anchor Investors | 1 |
| Market Maker | 1 |
| Qualified Institutions | 105.27 |
| Non-Institutional Buyers*** | 236.62 |
| bNII (bids above ₹10L) | 165.26 |
| sNII (bids below ₹10L) | 204.81 |
| Individual Investors (IND category bidding for 2 Lots) | 173.03 |
| Total ** | 167.32 |
Anchor Investors
1
Market Maker
1
Qualified Institutions
105.27
Non-Institutional Buyers***
236.62
bNII (bids above ₹10L)
165.26
sNII (bids below ₹10L)
204.81
Individual Investors (IND category bidding for 2 Lots)
173.03
Total **
167.32
Day Wise Sub
| Day | QIB | NII* | NII (> ₹10L) | NII (< ₹10L) | Individual Investors | Total |
|---|---|---|---|---|---|---|
| Day 1 Jul 25, 2025 | 0.01 | 3.27 | 3.93 | 1.95 | 3.46 | 2.44 |
| Day 2 Jul 28, 2025 | 1.01 | 17.80 | 18.31 | 17.86 | 30.26 | 19.25 |
| Day 3 Jul 29, 2025 | 105.27 | 236.62 | 165.26 | 204.81 | 173.03 | 167.32 |
DayDay 1
Jul 25, 2025
QIB0.01
NII*3.27
NII (> ₹10L)3.93
NII (< ₹10L)1.95
Individual Investors3.46
Total2.44
DayDay 2
Jul 28, 2025
QIB1.01
NII*17.80
NII (> ₹10L)18.31
NII (< ₹10L)17.86
Individual Investors30.26
Total19.25
DayDay 3
Jul 29, 2025
QIB105.27
NII*236.62
NII (> ₹10L)165.26
NII (< ₹10L)204.81
Individual Investors173.03
Total167.32
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 01-08-2025 | 84.00 | 27(32.14%) | 2800 |
| 31-07-2025 | 84.00 | 27(32.14%) | 2800 |
| 30-07-2025 | 84.00 | 31(36.90%) | 7700 |
| 29-07-2025 | 84.00 | 35(41.67%) | 2600 |
| 28-07-2025 | 84.00 | 40(47.62%) | 8600 |
| 27-07-2025 | 84.00 | 45(53.57%) | 4700 |
| 26-07-2025 | 84.00 | 45(53.57%) | 4700 |
| 25-07-2025 | 84.00 | 45(53.57%) | 4700 |
| 24-07-2025 | 84.00 | 35(41.67%) | 2600 |
| 23-07-2025 | 84.00 | 23(27.38%) | 8000 |
| 22-07-2025 | 84.00 | 18(21.43%) | 1900 |
| 21-07-2025 | 84.00 | 16(19.05%) | 9500 |
| 20-07-2025 | 84.00 | 12(14.29%) | 4600 |
| 19-07-2025 | 84.00 | 11(13.10%) | 3400 |
| 18-07-2025 | 84.00 | 0(0.00%) | - |
Date01-08-2025
Price84.00
GMP27(32.14%)
Estimate List Price2800
Date31-07-2025
Price84.00
GMP27(32.14%)
Estimate List Price2800
Date30-07-2025
Price84.00
GMP31(36.90%)
Estimate List Price7700
Date29-07-2025
Price84.00
GMP35(41.67%)
Estimate List Price2600
Date28-07-2025
Price84.00
GMP40(47.62%)
Estimate List Price8600
Date27-07-2025
Price84.00
GMP45(53.57%)
Estimate List Price4700
Date26-07-2025
Price84.00
GMP45(53.57%)
Estimate List Price4700
Date25-07-2025
Price84.00
GMP45(53.57%)
Estimate List Price4700
Date24-07-2025
Price84.00
GMP35(41.67%)
Estimate List Price2600
Date23-07-2025
Price84.00
GMP23(27.38%)
Estimate List Price8000
Date22-07-2025
Price84.00
GMP18(21.43%)
Estimate List Price1900
Date21-07-2025
Price84.00
GMP16(19.05%)
Estimate List Price9500
Date20-07-2025
Price84.00
GMP12(14.29%)
Estimate List Price4600
Date19-07-2025
Price84.00
GMP11(13.10%)
Estimate List Price3400
Date18-07-2025
Price84.00
GMP0(0.00%)
Estimate List Price-
IPO Important Dates
| IPO Open Date | Fri, Jul 25, 2025 |
| IPO Close Date | Tue, Jul 29, 2025 |
| Tentative Allotment | Wed, Jul 30, 2025 |
| Initiation of Refunds | Thu, Jul 31, 2025 |
| Credit of Shares to Demat | Thu, Jul 31, 2025 |
| Tentative Listing Date | Fri, Aug 1, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 29, 2025 |
IPO Open Date
Fri, Jul 25, 2025
IPO Close Date
Tue, Jul 29, 2025
Tentative Allotment
Wed, Jul 30, 2025
Initiation of Refunds
Thu, Jul 31, 2025
Credit of Shares to Demat
Thu, Jul 31, 2025
Tentative Listing Date
Fri, Aug 1, 2025
Cut-off time for UPI mandate confirmation
5 PM on July 29, 2025
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 3,200 | ₹2,68,800 |
| Individual investors (Retail) (Max) | 2 | 3,200 | ₹2,68,800 |
| S-HNI (Min) | 3 | 4,800 | ₹4,03,200 |
| S-HNI (Max) | 7 | 11,200 | ₹9,40,800 |
| B-HNI (Min) | 8 | 12,800 | ₹10,75,200 |
ApplicationIndividual investors (Retail) (Min)
Lots2
Shares3,200
Amount₹2,68,800
ApplicationIndividual investors (Retail) (Max)
Lots2
Shares3,200
Amount₹2,68,800
ApplicationS-HNI (Min)
Lots3
Shares4,800
Amount₹4,03,200
ApplicationS-HNI (Max)
Lots7
Shares11,200
Amount₹9,40,800
ApplicationB-HNI (Min)
Lots8
Shares12,800
Amount₹10,75,200
Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 65.31 | 46.97 | 37.08 |
| Total Income | 105.55 | 82.72 | 69.75 |
| Profit After Tax | 10.57 | 7.66 | 2.89 |
| EBITDA | 15.80 | 12.02 | 5.83 |
| Net Worth | 35.40 | 19.52 | 11.87 |
| Reserves and Surplus | 17.53 | 18.52 | 10.87 |
| Total Borrowing | 14.85 | 15.46 | 11.79 |
Period EndedPeriod Ended
31 Mar 202531 Mar 2025
31 Mar 202431 Mar 2024
31 Mar 202331 Mar 2023
Period EndedAssets
31 Mar 202565.31
31 Mar 202446.97
31 Mar 202337.08
Period EndedTotal Income
31 Mar 2025105.55
31 Mar 202482.72
31 Mar 202369.75
Period EndedProfit After Tax
31 Mar 202510.57
31 Mar 20247.66
31 Mar 20232.89
Period EndedEBITDA
31 Mar 202515.80
31 Mar 202412.02
31 Mar 20235.83
Period EndedNet Worth
31 Mar 202535.40
31 Mar 202419.52
31 Mar 202311.87
Period EndedReserves and Surplus
31 Mar 202517.53
31 Mar 202418.52
31 Mar 202310.87
Period EndedTotal Borrowing
31 Mar 202514.85
31 Mar 202415.46
31 Mar 202311.79
Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio |
|---|---|---|---|---|---|---|
| Patel Chem Specialities Limited | 6.10 | 6.10 | 20.44 | 29.85 | ||
| Accent Microcell Limited | 15.71 | 15.71 | 92.57 | 16.26 | 16.97 | |
| Sigachi Industries Limited | 2.06 | 2.06 | 15.72 | 20.51 | 11.73 | 3.67 |
Company NamePatel Chem Specialities Limited
EPS (Basic)6.10
EPS (Diluted)6.10
NAV (per share) (Rs)20.44
P/E (x)
RoNW (%)29.85
P/BV Ratio
Company NameAccent Microcell Limited
EPS (Basic)15.71
EPS (Diluted)15.71
NAV (per share) (Rs)92.57
P/E (x)16.26
RoNW (%)16.97
P/BV Ratio
Company NameSigachi Industries Limited
EPS (Basic)2.06
EPS (Diluted)2.06
NAV (per share) (Rs)15.72
P/E (x)20.51
RoNW (%)11.73
P/BV Ratio3.67
IPO Reservation
| Market Maker Shares Offered | 3,53,600 (5.05%) |
| QIB Shares Offered | 33,16,800 (47.38%) |
| − Anchor Investor Shares Offered | 19,87,200 (28.39%) |
| − QIB (Ex. Anchor) Shares Offered | 13,29,600 (18.99%) |
| NII (HNI) Shares Offered | 9,98,400 (14.26%) |
| − bNII > ₹10L | 6,65,600 (9.51%) |
| − sNII < ₹10L | 3,32,800 (4.75%) |
| Retail Shares Offered | 23,31,200 (33.30%) |
| Total Shares Offered | 70,00,000 (100.00%) |
Market Maker Shares Offered
3,53,600 (5.05%)
QIB Shares Offered
33,16,800 (47.38%)
− Anchor Investor Shares Offered
19,87,200 (28.39%)
− QIB (Ex. Anchor) Shares Offered
13,29,600 (18.99%)
NII (HNI) Shares Offered
9,98,400 (14.26%)
− bNII > ₹10L
6,65,600 (9.51%)
− sNII < ₹10L
3,32,800 (4.75%)
Retail Shares Offered
23,31,200 (33.30%)
Total Shares Offered
70,00,000 (100.00%)
Information about company
Incorporated in 2008, Patel Chem Specialities Limited (PCSL) is engaged in the manufacturing and exporting pharmaceutical excipients and specialty chemicals.
The company manufactures various essential chemicals used in pharmaceuticals, food, cosmetics, and industrial applications, serving as binders, disintegrants, thickeners, stabilizers, and gelling agents across industries.
The company’s manufacturing facilities in Vatva, Ahmedabad, and Talod, Himmatnagar, follow strict quality control standards, ensuring bulk production of chemicals that meet international certifications like US-DMF and GMP.
The company’s manufacturing facility covers 7,000 square yards, with a capacity of over 7,200 MT annually for pharmaceutical excipients, featuring departments for storage, production, R&D, quality control, packaging, and warehousing.
The company has expanded globally, serving East Asia, Europe, the Middle East, North America, and Southeast Asia, delivering high-quality products that meet international standards to lead the chemical industry.
Product Portfolio:
Rheollose® (Sodium Carboxymethyl Cellulose): A cellulose gum used as a thickening and stabilizing agent in various applications.
Disolwell® (Croscarmellose Sodium): A super disintegrant used in oral pharmaceutical formulations to enhance tablet disintegration.
Swellcal® (Calcium Carboxymethyl Cellulose): Used as a super disintegrant in pharmaceutical applications.
AmyloTab™ (Pregelatinized Starch): Used in tablet formulations to aid in the disintegration and dissolution processes.
As of March 31, 2025, the company has a total strength of 136 employees.
Objectives of IPO
The Company Patel Chem Specialities IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
S.No.
Objects of the Issue
Expected Amount (₹ in crores)
1
Funding capital expenditure requirement of the Company
43.15
2
General corporate purposes
8.40
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App